Collagen synthesis and extracellular matrix remodeling

Collagen synthesis and extracellular matrix remodeling represents a complex biological process rather than a single therapeutic target. This process involves the coordinated synthesis, modification, degradation, and reorganization of extracellular matrix components, particularly collagen[1][2]. The process includes intracellular synthesis of ECM components in the endoplasmic reticulum and Golgi apparatus, followed by secretion and assembly into organized networks[2]. Key mechanisms include enzymatic cross-linking by lysyl oxidases and lysyl oxidase-like enzymes, which increase matrix stiffness and tensile strength[1][3]. Matrix degradation occurs through various enzymes including matrix metalloproteinases, cathepsins, and other proteases that maintain ECM homeostasis[1]. This dynamic remodeling is essential for tissue development, wound healing, and maintaining structural integrity[2][4]. The process is dysregulated in numerous pathological conditions including cancer, where altered ECM properties contribute to tumor progression and metastasis[3], and fibrotic diseases where excessive matrix deposition occurs[1]. Rather than targeting a single molecule, therapeutic interventions typically focus on specific enzymes within these pathways, such as matrix metalloproteinases or lysyl oxidases, making this designation too broad to constitute a single therapeutic target.

Other names

ECM remodelingMatrix remodelingCollagen metabolismExtracellular matrix turnoverMatrix synthesis and degradation

Matrix metalloproteinase inhibition, Lysyl oxidase inhibition, Collagen cross-linking inhibition, Growth factor sequestration modulation